Cogent Biosciences Inc Capital Reinvestment Ratio

Latest as of December 2015: 0.11x

Cogent Biosciences Inc capital reinvestment ratio. Cogent Biosciences Inc (COGT) has a Capital Reinvestment Ratio of 0.11x as of December 2015, meaning it reinvests 0% of its operating cash flow ($17.72 Million) in capital expenditures ($1.99 Million). Check Cogent Biosciences Inc (COGT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

$17.72 Million
USD

Capital Expenditures

$1.99 Million
USD

Data as of

Dec 2015
Most recent filing

Capital Reinvestment Ratio of Cogent Biosciences Inc (2015–2015)

Capital reinvestment ratio of Cogent Biosciences Inc from 2015 to 2015. This chart tracks Cogent Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Cogent Biosciences Inc (COGT) net asset momentum to track the company's year-over-year net asset growth rate.

Cogent Biosciences Inc Capital Reinvestment Ratio by Year (2015–2015)

Cogent Biosciences Inc capital reinvestment ratio by year from 2015 to 2015. For the full cash flow conversion analysis, see Cogent Biosciences Inc operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2015 0.11x $17.72 Million $1.99 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow